These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1435007)

  • 1. [Genetic changes in carcinoma of the colon].
    Lazo PA
    Med Clin (Barc); 1992 Sep; 99(9):350-4. PubMed ID: 1435007
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular pathogenesis of colorectal cancer.
    Hoops TC; Traber PG
    Hematol Oncol Clin North Am; 1997 Aug; 11(4):609-33. PubMed ID: 9257148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular genetics of human pancreatic cancer].
    Villanueva A; Capellá G; Mangues R; Farré A; Lluís F
    Gastroenterol Hepatol; 1999 Nov; 22(9):444-50. PubMed ID: 10638042
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer.
    Fong KM; Zimmerman PV; Smith PJ
    Cancer Res; 1995 Jan; 55(2):220-3. PubMed ID: 7812947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic alterations of human colorectal cancer].
    Suzuki T; Ishioka C; Gamo M; Niitani T; Shimodaira H; Kanbe M; Yamazaki T; Yusa Y; Kanamaru R
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):343-50. PubMed ID: 8109990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Colonic carcinoma associated with ulcerative colitis. Risk factors, molecular pathogenesis and surveillance].
    Schürmann G; Ochman S; Neurath MF
    Dtsch Med Wochenschr; 2000 Sep; 125(36):1045-50. PubMed ID: 11022601
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tumor suppressor genes in cancers of colon and rectum].
    Thomas G; Olschwang S; Laurent-Puig P
    Rev Prat; 1991 Nov; 41(23):2313-5. PubMed ID: 1792493
    [No Abstract]   [Full Text] [Related]  

  • 8. [The possible role of loss of heterozygosity at APC, MCC and DCC genetic loci in esophageal carcinoma].
    Wang M; Lu R; Fang D
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):16-8. PubMed ID: 11776787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The capacity for growth stimulation by TGF beta 1 seen only in advanced colon cancers cannot be ascribed to mutations in APC, DCC, p53 or ras.
    Huang F; Hsu S; Yan Z; Winawer S; Friedman E
    Oncogene; 1994 Dec; 9(12):3701-6. PubMed ID: 7970729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction.
    Cawkwell L; Lewis FA; Quirke P
    Br J Cancer; 1994 Nov; 70(5):813-8. PubMed ID: 7947085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological consequences of the genetic changes which occur during human colorectal carcinogenesis.
    Williams AC; Browne SJ; Manning AM; Hague A; van der Stappen JW; Paraskeva C
    Semin Cancer Biol; 1993 Jun; 4(3):153-9. PubMed ID: 8318691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of the adenomatous polyposis coli (Apc) and mutated in colorectal cancer (Mcc) genes in mouse lung neoplasia.
    Oreffo VI; Robinson S; You M; Wu MC; Malkinson AM
    Mol Carcinog; 1998 Jan; 21(1):37-49. PubMed ID: 9473770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oncogenes and tumor suppressor genes: genetic changes mark the adenoma-carcinoma sequence].
    Schmiegel WH
    Internist (Berl); 1991 Jun; 32(6):315-20. PubMed ID: 1652573
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular genetics of colorectal cancer (part 1).
    Wilson RH; Whiteside MC; Russell SE
    Clin Oncol (R Coll Radiol); 1997; 9(1):14-9. PubMed ID: 9039808
    [No Abstract]   [Full Text] [Related]  

  • 15. [Development of molecular genetics of chromosome and the clinical application for diagnosis of colonic polyps].
    Sugio K; Sasaki M; Wake N; Toshitani K; Sasazuki T
    Nihon Rinsho; 1991 Dec; 49(12):82-7. PubMed ID: 1686287
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic alterations associated with bladder cancer.
    Cordon-Cardo C; Dalbagni G; Sarkis AS; Reuter VE
    Important Adv Oncol; 1994; ():71-83. PubMed ID: 7911446
    [No Abstract]   [Full Text] [Related]  

  • 17. Loss of heterozygosity affecting the APC and MCC genetic loci in patients with primary breast carcinomas.
    Medeiros AC; Nagai MA; Neto MM; Brentani RR
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):331-3. PubMed ID: 8061582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
    Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
    Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The putative tumor suppressor gene on chromosome 5q for hepatocellular carcinoma is distinct from the MCC and APC genes.
    Ding SF; Delhanty JD; Dooley JS; Bowles L; Wood CB; Habib NA
    Cancer Detect Prev; 1993; 17(3):405-9. PubMed ID: 8402727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene TP53 and digestive cancers].
    Tominaga O; Salmon RJ; Laurent-Puig P
    Gastroenterol Clin Biol; 1993; 17(3):187-96. PubMed ID: 8392475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.